Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.16)
# 2,634
Out of 4,413 analysts
56
Total ratings
41.67%
Success rate
-10.17%
Average return
Main Sectors:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $12.99 | +53.96% | 6 | Mar 14, 2024 | |
| NVRO Nevro | Maintains: Equal-Weight | $20 → $17 | $10.58 | +60.68% | 10 | Feb 22, 2024 | |
| ABT Abbott Laboratories | Maintains: Overweight | $116 → $121 | $105.97 | +14.18% | 3 | Dec 13, 2023 | |
| PODD Insulet | Maintains: Overweight | $375 → $300 | $171.94 | +74.48% | 2 | Aug 9, 2023 | |
| SWAV ShockWave Medical | Maintains: Overweight | $255 → $300 | $330.19 | -9.14% | 7 | Nov 8, 2022 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $36.69 | +123.49% | 4 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $208.75 | +18.80% | 1 | Jul 29, 2022 | |
| BDX Becton, Dickinson and Company | Upgrades: Overweight | $275 | $234.60 | +17.22% | 3 | Jun 24, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $370.62 | -8.53% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $4.27 | -64.87% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $7.61 | +254.80% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $120.28 | -7.72% | 2 | Feb 8, 2022 | |
| DXCM DexCom | Upgrades: Overweight | $144 | $127.39 | +12.84% | 1 | Jan 19, 2022 | |
| GKOS Glaukos | Upgrades: Equal-Weight | $56 | $96.00 | -41.67% | 4 | Jan 19, 2022 | |
| MMSI Merit Medical Systems | Maintains: Equal-Weight | n/a | $74.10 | - | 4 | Oct 29, 2021 | |
| EW Edwards Lifesciences | Downgrades: Equal-Weight | n/a | $84.67 | - | 1 | Apr 28, 2020 | |
| NVCR NovoCure | Upgrades: Overweight | n/a | $12.24 | - | 1 | Mar 5, 2020 | |
| GMED Globus Medical | Upgrades: Overweight | n/a | $49.79 | - | 1 | Dec 12, 2019 |
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $12.99
Upside: +53.96%
Nevro
Feb 22, 2024
Maintains: Equal-Weight
Price Target: $20 → $17
Current: $10.58
Upside: +60.68%
Abbott Laboratories
Dec 13, 2023
Maintains: Overweight
Price Target: $116 → $121
Current: $105.97
Upside: +14.18%
Insulet
Aug 9, 2023
Maintains: Overweight
Price Target: $375 → $300
Current: $171.94
Upside: +74.48%
ShockWave Medical
Nov 8, 2022
Maintains: Overweight
Price Target: $255 → $300
Current: $330.19
Upside: -9.14%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $36.69
Upside: +123.49%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $208.75
Upside: +18.80%
Becton, Dickinson and Company
Jun 24, 2022
Upgrades: Overweight
Price Target: $275
Current: $234.60
Upside: +17.22%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $370.62
Upside: -8.53%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $4.27
Upside: -64.87%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $7.61
Upside: +254.80%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $120.28
Upside: -7.72%
DexCom
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $127.39
Upside: +12.84%
Glaukos
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $96.00
Upside: -41.67%
Merit Medical Systems
Oct 29, 2021
Maintains: Equal-Weight
Price Target: n/a
Current: $74.10
Upside: -
Edwards Lifesciences
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $84.67
Upside: -
NovoCure
Mar 5, 2020
Upgrades: Overweight
Price Target: n/a
Current: $12.24
Upside: -
Globus Medical
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $49.79
Upside: -